Explore Patheon by the numbers
Patheon, a part of Thermo Fisher Scientific,is a transformative force within the industry, leading the evolution of the pharma supply chain. We offer solutions spanning the entire pharmaceutical life cycle to help pharma and biotech companies of all sizes meet their complex development and manufacturing needs at any stage or scale. We deliver a combination of unrivaled quality, reliability and compliance, backed by a reputation for scientific and technical excellence.
Learn more about Patheon, a part of Thermo Fisher Scientific, on our company profile.
We believe the world would be a healthier place if tomorrow’s medicines were made available today. Our goal is to become your trusted partner – with end-to-end capabilities and reliable quality – in rapidly turning your pharmaceutical possibilities into reality.
The range of services at Patheon for drug substances and drug products is wider than that of any other CDMO. We offer end-to-end capabilities and expertise to take your discovery from preclinincal and clinical development, through scale-up, all the way to commercial supply across more than 40 oral solid, sterile and softgel dosage forms.
Patheon has a diverse roster of clients from every sector of the industry. The largest represents only 7% of revenues, and the top product represents only 3%. In fact, our top 10 clients represent only 41% of our consolidated revenue base. Our agreements range from long-term strategic partnerships to short-term contracts. This widely varied revenue stream creates the stability that companies count on for steady development progress and uninterrupted commercial supply.
Patheon business segments include:
Drug Substance Services (DSS): Patheon is a leading provider of complex small molecule active pharmaceutical ingredient (API) and flexible outsourced manufacturing solutions for large molecule API, from early development through commercial scale production. The company is one of the top three outsourced manufacturers of highly complex biological drug substances, with four biologics API facilities positioned to service 70 percent of the market.
Pharmaceutical Development Services (PDS): Patheon is the number one global provider of formulation services. The company’s capabilities span the full breadth of advanced scientific services from discovery to regulatory approval, including formulation development across approximately 40 dosage forms, as well as analytical services and life-cycle management.
Drug Product Services (DPS): Patheon is the number one provider of contract drug manufacturing services. Over the past decade, the company has developed and manufactured 20 percent of the top 100 drugs and 75 percent of the dosage forms on the market.
Patheon is forging partnerships that are transforming the industry, creating new business models between pharma companies and their pharma service providers. The company is pioneering solutions that are driven by client needs, with successful recent partnerships including Amgen, Flexion, Pacira and Grünenthal. Patheon’s transformational business models include:
Patheon is a world leader in small molecule development and manufacturing. Our global capabilities include comprehensive and scalable active pharmaceutical ingredient (API) services to meet demand at each stage of a product’s life cycle, complete drug product services from preformulation screening through clinical development and large scale commercial supply from our fully integrated global network of commercial manufacturing facilities. We provide a comprehensive range of oral solid, sterile and softgel dosage forms, as well as specialty expertise in high-potency products and solubility enhancement solutions that accelerate the path to proof of concept.
Learn more about our small molecule capabilities.
Learn more about our biologics capabilities.